Amerise Biosciences has informed that Annual Secretarial Compliance Report under regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018 read with BSE Circular dated 9th May, 2019 is not applicable to the Company. Further, the company has clarified that the Company is claiming exemption under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 as Corporate Governance provision shall not apply to listed entities having paid up Equity Share Capital not exceeding Rupees 10 Crores and net worth not exceeding Rupees 25 Crores, as on the day of previous financial year. Hence, the company is not required to submit Annual Secretarial Compliance Report as the Company is exempted under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
